Analyzers, Point-of-Care, Whole Blood/Urine, Multianalyte, Diabetes

Definition : Multianalyte point-of-care analyzers designed to determine the concentration of analytes in the blood and urine that is appropriate for diabetes disease management. The most frequently measured analytes are glycated hemoglobin (GHB), also known as glycohemoglobin, in whole blood, and urine creatinine and albumin. The amount of GHB in blood represents the integrated values for glucose for the previous three months; the value of the albumin/creatinine ratio may be an indicator of microalbuminuria. These devices typically consist of a portable analyzer that includes a reagent cartridge to collect and assess the samples; they may use several measuring techniques, including photometry and immunoassay. Point-of-care analyzers for diabetes management are used in clinics and physician's offices to obtain criteria in assessing glucose control and/or to find early signs of possible diabetes-related nephropathy.

Entry Terms : "Immunoassay Analyzers, Point-of-Care, Diabetes Management" , "HA1c Analyzers" , "HbA1c Analyzers" , "Hemoglobin A1c Analyzers" , "Glycated Hemoglobin (GHb) Analyzers" , "Glycohemoglobin Analyzers" , "Glycosylated Hemoglobin Analyzers"

UMDC code : 20386

U.S.companies only
Suppress Subsidiary Companies

1-3 of 3 Match(es).

American Screening Corp

Company Type: Parent

Ascensia Diabetes Care US Inc

Company Type: Parent

Mayo Medical Laboratories

Company Type: Parent

1-3 of 3 Match(es).


Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs
Medical Product Guide Cancer Therapy Advisor Product Zone